Ticker Symbol: VVESF

Vivesto AB

Exchange: OTC MARKETS Country: Sweden Currency: USD Asset Type: Common Stock CIK:0001607245

Company Profile

oasmia pharmaceutical ab develops a new generation of drugs within human and veterinary oncology. the product development aims to manufacture novel formulations based on well-established cytostatics which, in comparison with current alternatives, show improved properties, a reduced side-effect profile and an expanded therapeutic area. the product development is based on in-house research within nanotechnology and company patents.

Sector: Manufacturing

Industry: Pharmaceutical Preparation Manufacturing

Standard Industrial Classification Code (SIC code): 2834

Address: Vallongatan 1

Website: http://www.oasmia.se/

CEO: Francois Martelet

Tags: N/A

Pricing

Last Updated: December 31, 1969 07:00 PM EST

Previous Close: -

Change: - ( 0.00%)

Days Range: $0.06 - $0.06

Beta: -

52wk. High: -

52wk. Low: -

Ytd. Change 0.00%

50 Day Moving Average: -

200 Day Moving Average: -

Shares Outstanding: 538043455

Valuation

Market Cap: -

PE Ratio: -

EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -

Dividend Yield (TTM): 0.00%

Ex-Dividend Date: N/A